We Think That There Are More Issues For Sino BiologicalInc (SZSE:301047) Than Just Sluggish Earnings
We Think That There Are More Issues For Sino BiologicalInc (SZSE:301047) Than Just Sluggish Earnings
Sino Biological,Inc.'s (SZSE:301047) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.
Sino Biological,Inc. (SZSE:301047) 最近发布的疲弱财报并未引起股票大幅波动。然而,我们认为投资者应该注意一些潜在的可能令人担忧的因素。

How Do Unusual Items Influence Profit?
非常规项目如何影响利润?
To properly understand Sino BiologicalInc's profit results, we need to consider the CN¥20m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. Sino BiologicalInc had a rather significant contribution from unusual items relative to its profit to September 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.
为了充分了解Sino BiologicalInc的盈利结果,我们需要考虑到飞凡事项所贡献的2,000万人民币收益。我们不得不承认,更高的盈利通常让我们乐观,但我们更希望盈利能够持续。当我们分析全球大多数上市公司时,我们发现重要的飞凡事项通常不会重复出现。这并不奇怪,鉴于其名称。与2024年9月相比,Sino BiologicalInc相对于其利润有相当大比例来自飞凡事项。其他条件相同的情况下,这可能会导致法定利润成为衡量基础盈利能力的不良指标。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。
Our Take On Sino BiologicalInc's Profit Performance
我们对Sino BiologicalInc的盈利表现的看法
As we discussed above, we think the significant positive unusual item makes Sino BiologicalInc's earnings a poor guide to its underlying profitability. For this reason, we think that Sino BiologicalInc's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. Sadly, its EPS was down over the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For instance, we've identified 2 warning signs for Sino BiologicalInc (1 is concerning) you should be familiar with.
正如我们上面讨论的那样,我们认为重大的正向飞凡项目使得Sino BiologicalInc的盈利成为其潜在盈利能力的不良指引。因此,我们认为Sino BiologicalInc的法定利润可能是其潜在盈利能力的糟糕指引,并可能给投资者对该公司过于积极的印象。遗憾的是,其每股收益在过去十二个月下降了。当然,在分析其盈利方面我们只是触及了皮毛;人们也可以考虑利润率、预测增长、投资回报等其他因素。因此,如果您想深入了解这支股票,考虑到它所面临的任何风险是至关重要的。例如,我们已经为Sino BiologicalInc确定了2个警示信号(其中1个令人担忧),您应该熟悉。
Today we've zoomed in on a single data point to better understand the nature of Sino BiologicalInc's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
今天我们聚焦在一个数据点上,以更好地了解Sino BiologicalInc盈利的性质。但如果您能够专注心思到细微之处,总是有更多发现的。例如,许多人认为高股本回报率是有利的商业经济指标,而另一些人则喜欢“跟着钱走”,寻找内部人员正在购买的股票。虽然您可能需要进行一些研究,但您可能会发现这个收集了高股本回报率公司的免费资料,或者这份具有重要内部持股的股票清单是有用的。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。